References

gastro-j

Российский журнал гастроэнтерологии, гепатологии, колопроктологии

Russian Journal of Gastroenterology, Hepatology, Coloproctology

1382-43762658-6673

«Gastro» LLC

10.22416/1382-4376-2019-29-6-49-59

gastro-j-428

Research Article

КЛИНИЧЕСКИЕ НАБЛЮДЕНИЯ

CLINICAL CASES

Нейроэндокринная опухоль как диагностический и прогностический критерий аутоиммунного гастрита

Neuroendocrine Tumour as a Diagnostic and Prognostic Criterion for Autoimmune Gastritis

https://orcid.org/0000-0001-7200-7082

Мозговой

С. И.

Mozgovoi

S. I.

д.м.н., доцент, профессор кафедры патологической анатомии

644099, г. Омск, ул. Ленина, д. 12

Dr. Sci. (Med.), Prof., Department of Pathological Anatomy

644099, Omsk, Lenina str., 12

simozgovoy@yandex.com

https://orcid.org/0000-0002-6581-7017

Ливзан

М. А.

Livzan

M. A.

д.м.н., профессор, заведующий кафедрой факультетской терапии, профессиональных болезней

644099, г. Омск, ул. Ленина, д. 12

mlivzan@yandex.ru

https://orcid.org/0000-0002-7452-7230

Кролевец

Т. С.

Krolevets

T. S.

к.м.н., ассистент кафедры факультетской терапии, профессиональных болезней

644099, г. Омск, ул. Ленина, д. 12

mts-8-90@mail.ru

https://orcid.org/0000-0003-0949-8709

Шиманская

А. Г.

Shimanskaya

A. G.

к.м.н., доцент кафедры патологической анатомии

644099, г. Омск, ул. Ленина, д. 12

mts-8-90@mail.ru

ФГБОУ ВО «Омский государственный медицинский университет» Министерства здравоохранения Российской ФедерацииOmsk State Medical University

2019

12012020

2964959

2020

Мозговой С.И., Ливзан М.А., Кролевец Т.С., Шиманская А.Г.

Mozgovoi S.I., Livzan M.A., Krolevets T.S., Shimanskaya A.G.

Данная работа распространяется под лицензией Creative Commons Attribution 4.0.

This work is licensed under a Creative Commons Attribution 4.0 License.

https://www.gastro-j.ru/jour/article/view/428

аутоиммунный гастритнейроэндокринные опухоли желудка

autoimmune gastritisneuroendocrine tumours of the stomachtacticsprognosis

References1

Anlauf M., Gerlach P., Schott M., Raffel A., Krausch M., Knoefel W.T., Pavel M., Kloppel G. Pathology of neuroendocrine neoplasms. Chirurg. 2011;82(7):567–573.

Caplin M., Yao J.C. An overview of thoracic and gastrointestinal neuroendocrine tumours. In: M. Caplin, J.C. Yao (eds.). Handbook of Gastroenteropancreatic and Thoracic Neuroendocrine Tumours. BioScientifica. 2011. P. 1–9.

Gianfranco DelleFave, Dik J. Kwekkeboom, Erik Van Cutsem, Guido Rindi, Beata Kos-Kudla, Ulrich Knigge, Hironobu Sasano, Paola Tomassetti, Ramon Salazar, Philippe Ruszniewski, all other Barcelona Consensus Conference participants. ENETS Consensus Guidelines for the Management of Patients with Gastroduodenal Neoplasms. Neuroendocrinology 2012;95:74–87. DOI: 10.1159/000335595

G. DelleFave, A. Sundin, B. Taal, P. Ferolla, J.K. Ramage, D. Ferone, T. Ito, W. Weber, Z. Zheng-Pei, W.W. De Herder, A. Pascher, P. Ruszniewski, all other Vienna Consensus Conference participants. ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms. Neuroendocrinology 2016;103:119–124. DOI: 10.1159/000443168

Ливзан М.А., Лялюкова Е.А., Костенко М.Б. Нестероидные противовоспалительные препараты: оценка рисков и пути повышения безопасности терапии. Лечащийврач. 2016;5:78.

Livzan M.A., Lyalyukova E.A., Kostenko M.B. Non-steroid anti-inflammatory preparations: risk assessment and ways of the therapy safety enhancement. Lechashhij vrach. 2016;5:78 (In Rus.)

Бохян В.Ю., Бельцевич Д.Г., Вашакмадзе Л.А. и др. Клинические рекомендации по лечению нейроэндокринных опухолей. Общероссийский союз общественных объединений. Ассоциация онкологов России. Утверждено на Заседании правления Ассоциации онкологов России. Москва 2014. 28 стр.

Bohjan V.Ju., Bel’cevich D.G., Vashakmadze L.A. et al. Clinical recommendations for the treatment of neuroendocrine tumors. All-Russian Union of Public Associations. Association of Oncologists of Russia. Approved at the Board meeting of the Association of Oncologists of Russia. Moscow; 2014. 28 p. (In Rus.)

Rugge M., Correa P., Di Mario F. et al. OLGA staging for gastritis: a tutorial. Dig Liver Dis. 2008;40(8):650-8. DOI: 10.1016/j.dld.2008.02.030

Niederle M.B., Hackl M., Kaserer K. et al: Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters. EndocrRelatCancer2010;17:909–918. doi: 10.1677/ERC-10-0152.

Rindi G, Luinetti O, Cornaggia M, et al: Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study. Gastroenterology 1993; 104: 994–1006. https://moh-it.pure.elsevier.com/en/publications/three-subtypes-of-gastric-argyrophil-carcinoid-and-the-gastric-ne

Coburn N. et al. Staging and surgical approaches in gastric cancer: A systematic review. Cancer Treat. Rev. 2018; 63:104-115. doi: 10.1016/j.ctrv.2017.12.006.

Vannella L, Sbrozzi-Vanni A, Lahner E, etal: Development of type I gastric carcinoid in patients with chronic atrophic gastritis. Aliment PharmacolTher2011;33:1361–1369. doi: 10.1111/j.1365-2036.2011.04659.x.

Borch K, Ahren B, Ahlman H, et al: Gastric carcinoids: biologic behavior and prognosis after differentiated treatment in relation to type. Ann Surg 2005; 242:64–73. https://www.ncbi.nlm.nih.gov/pubmed/15973103

Vanella Marignani M, Delle Fave G, Mecarocci S, et al: High prevalence of atrophic body gastritis in patients with unexplained microcytic and macrocytic anemia. A prospective screening study. Am J Gastroenterol 1999;94:766–772. https://www.ncbi.nlm.nih.gov/pubmed/10086664

Merola E, Sbrozzi-Vanni A, Panzuto F, et al: Type I gastric carcinoids: a prospective study on endoscopic management and recurrencerate. Neuroendocrinology 2011 (E-pub ahead of print).

F. Gibril, M. Schumann, A. Pace, and R. T. Jensen. Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature. Medicine. 2004;83:43–83. https://www.ncbi.nlm.nih.gov/pubmed/14747767

Bordi C., Falchetti A., Azzonietal C. Aggressive form sofgastric neuroendocrine tumors in multiple endocrine neoplasia type I. American Journal of Surgical Pathology. 1997;21(9):1075–1082. https://www.pubfacts.com/detail/9298884/Aggressive-forms-of-gastric-neuroendocrine-tumors-in-multiple-endocrine-neoplasia-type-I

J. A. Norton, M. L. Melcher, F. Gibril, and R. T. Jensen. Gastric carcinoid tumors in multiple endocrine neoplasia-1 patients with Zollinger-Ellison syndrome can be symptomatic, demonstrate aggressive growth, and require surgical treatment. Surgery. 2004;136(6):1267–1274. https://www.ncbi.nlm.nih.gov/pubmed/15657586

M. M. Hassan, A. Phan, D. Li, C. G. Dagohoy, C. Leary, and J. C. Yao. Risk factors associated with neuroendocrine tumors: a U.S.-based case-control study. International Journal of Cancer. 2008;123(4):867–873. doi: 10.1002/ijc.23529.

A. Ooi, M. Ota, S. Katsuda, I. Nakanishi, H. Sugawara, and I. Takahashi. An unusual case of multiple gastric carcinoids associated with diffuse endocrine cell hyperplasia and parietal cell hypertrophy. Endocrine Pathology. 1995;6(3):229–237. https://www.ncbi.nlm.nih.gov/pubmed/12114744

C. M. Zhao and D. Chen. The ECL cell: relay station for gastric integrity. Current Medicinal Chemistry. 2012;19(1):98–108. https://www.ncbi.nlm.nih.gov/pubmed/22300082

M. F. Fanelli, L. T. Chinen, M. D. Begnami et al. The influence of transforming growth factor-α, cyclooxygenase-2, matrix metalloproteinase (MMP)-7, MMP-9 and CXCR4 proteins involved in epithelial-mesenchymal transition on overall survival of patients with gastric cancer. Histopathology. 2012;61(2):153–161. doi: 10.1111/j.1365-2559.2011.04139.x.

N. Hodgson, L. G. Koniaris, A. S. Livingstone, and D. Franceschi. Gastric carcinoids: a temporal increase with proton pump introduction. Surgical Endoscopy and other Interventional Techniques. 2005;19(12):1610–1612. https://www.ncbi.nlm.nih.gov/pubmed/16211437

M. Germain and R. S. Slack. MCL-1 regulates the balance between autophagy and apoptosis. Autophagy. 2011;7(5):549–551. https://doi.org/10.4161/auto.7.5.15098

Massironi S., Cavalcoli F., Rossi R.E. et al. Chronic autoimmune atrophic gastritis associated with primary hyperparathyroidism: a transversal prospective study. Eur J Endocrinol. 2013;168:755-61. doi: 10.1530/EJE-12-1067.

Мозговой С.И., Костенко М.Б., Кролевец Т.С., Ливзан М.А. Аутоиммунный гастрит в фокусе клинициста и морфолога. Фарматека. 2019;26(2):121–29. DOI: https: //dx.doi.org/10.18565/pharmateca.2019.2.121-129

Mozgovoy S.I., Kostenko M.B., Krolevets T.S., Livzan M.A. Autoimmune gastritis in the focus of clinician and morphologist. Farmateka. 2019;26(2):121–29. (in Russ.). DOI: https://dx.doi.org/10.18565/pharmateca.2019.2.121-129

Яковенко Э.П., Иванов А.Н., Илларионова Ю.В. идр. Хронический гастрит: диагностика и лечение. Фарматека. 2009;8:50–54.

Jakovenko Je.P., Ivanov A.N., Illarionova Ju.V. i dr. Hronicheskij gastrit: diagnostika i lechenie. Farmateka. 2009;8:50–54. (in Russ.)

Massironi S., Cavalcoli F., Rossi R.E., et al. Chronic autoimmune atrophic gastritis associated with primary hyperparathyroidism: a transversal prospective study. Eur J Endocrinol2013;168:755-761. doi: 10.1530/EJE-12-1067.

Amerio P., Tracanna M., De Remigis P., et al. Vitiligo associated with other autoimmune diseases: polyglandular autoimmune syndrome types 3 B+C and 4. ClinExpDermatol 2006;31:746-749. DOI: 10.1111/j.1365-2230.2006.02171.x

Ливзан М.А., Осипенко М.Ф., Заякина Н.В., Кролевец Т.С. Многоликая проблема непереносимости глютена. Клиническая медицина. 2018;96(2);123-128.

Oshima T., Okugawa T., Hori K., Kim Y., Tanaka J., Watari J., Miwa H. Successful endoscopic submucosal dissection of gastric carcinoid in a patient with autoimmune gastritis and systemic lupus erythematosus. InternMed. 2012;51(10):1211-3. DOI: 10.2169/internalmedicine.51.7077

Döcker D., Marx U., Braun B. Gastric neuroendocrine tumors in a woman with systemic lupus erythematosus. AbstractSend to Dtsch Med Wochenschr. 2010 Sep;135(36):1723-6. doi: 10.1055/s-0030-1263306.

Livsan M.A., Osipenko M.F., Zayakina Natalya V., Krolevets T.S. THE MANY FACES OF THE PROBLEM OF INTOLERANCE TO GLUTEN. Clinical Medicine. 2018;96(2);123-128. (in Russ.)

Neumann W.L., et al. Autoimmune atrophic gastritis – pathogenesis, pathology and management. Nat Rev Gastroenterol Hepatol. 2013;10(9):529–41. DOI: 10.1038/nrgastro.2013.101

Livsan M.A., Osipenko M.F., Zayakina Natalya V., Krolevets T.S. THE MANY FACES OF THE PROBLEM OF INTOLERANCE TO GLUTEN. Clinical Medicine. 2018;96(2);123-128. (in Russ.)

Cavallaro A., Zanghì A., Cavallaro M. et al: The role of 68-Ga-DOTATOC CT-PET in surgical tactic for gastric neuroendocrine tumors treatment: our experience: a case report. Int J Surg 2014; 12(suppl 1):S225–S231. doi: 10.1016/j.ijsu.2014.05.017.

Alexander H.R., Fraker D.L., Norton J.A., Barlett D.L., Tio L., Benjamin S.B., Doppman J.L., Goebel S.U., Serrano J., Gibril F., Jensen R.T. Prospective study of somatostatin receptor scintigraphy and its effect on operative outcome in patients with Zollinger-Ellison syndrome. Ann Surg1998;228:228–238. https://www.ncbi.nlm.nih.gov/pubmed/9712569

Rindi G., Klimstra D.S., Abedi-Ardekani B., Asa S.L. et al. A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Mod Pathol. 2018;31(12):1770-1786. doi: 10.1038/s41379-018-0110-y.

Döcker D., Marx U., Braun B. Gastric neuroendocrine tumors in a woman with systemic lupus erythematosus. AbstractSend to Dtsch Med Wochenschr. 2010 Sep;135(36):1723-6. doi: 10.1055/s-0030-1263306.

Lahner E., Norman G.L., Severi C., et al. Reassessment of intrinsic factor and parietal cell autoantibodies in atrophic gastritis with respect to cobalamin deficiency. Am J Gastroenterol. 2009;104(8):2071–79. doi: 10.1038/ ajg.2009.231.

Döcker D., Marx U., Braun B. Gastric neuroendocrine tumors in a woman with systemic lupus erythematosus. AbstractSend to Dtsch Med Wochenschr. 2010 Sep;135(36):1723-6. doi: 10.1055/s-0030-1263306.

Tozzoli R, Kodermaz G., Perosa A.R., et al. Autoantibodies to parietal cells as predictors of atrophic body gastritis: a five-year prospective study in patients with autoimmune thyroid diseases. Autoimmun Rev. 2010;10(2):80–3. Doi: 10.1016/j.autrev.2010.08.006

Neumann W.L., et al. Autoimmune atrophic gastritis – pathogenesis, pathology and management. Nat Rev Gastroenterol Hepatol. 2013;10(9):529–41. DOI: 10.1038/nrgastro.2013.101

Tozzoli R. The diagnostic role of autoantibodies in the prediction of organ-specific autoimmune diseases. ClinChem Lab Med. 2008;46(5): 577–87.

Neumann W.L., et al. Autoimmune atrophic gastritis – pathogenesis, pathology and management. Nat Rev Gastroenterol Hepatol. 2013;10(9):529–41. DOI: 10.1038/nrgastro.2013.101

Weck M.N., Brenner H. Association of Helicobacter pylori infection with chronic atrophic gastritis: Meta-analyses according to type of disease definition. Int. J. Cancer. 2008;123: 874–881. doi: 10.1002/ijc.23539.

Amedei, A., Bergman, M.P., Appelmelk, B., et al. Molecular mimicry between Helicobacter pylori antigens and H+K+-adenotriphosphatase in human gastric autoimmunity. J. Exp. Med. 2003;198:1147–1156. https://www.ncbi.nlm.nih.gov/pubmed/14568977

Niikura R, Hayakawa Y, Hirata Y, Ogura K, Fujishiro M, Yamada A, Ushiku T, Konishi M, Fukayama M, Koike K. The Reduction in Gastric Atrophy after Helicobacter pylori Eradication Is Reduced by Treatment with Inhibitors of Gastric Acid Secretion. Int J MolSci. 2019;20(8). pii: E1913. doi: 10.3390/ijms20081913.

Ливзан М.А., Мозговой С.И., Кононов А.В. Гастрит после эрадикации Helicobacter pylori - простые следы или серьезные последствия? Лечащий врач. 2011;7:7.

Ливзан М.А., Кононов А.В., Мозговой С.И. Постэрадикационный период хронического гастрита, ассоциированного с инфекцией Helicobacter pylori. ConsiliumMedicum. 2008;10(8):15-20.

Matysiak-Budnik T, Megraud F. Helicobacter pylori infection and gastric cancer. Eur J Cancer. 2006;42(6):708–16. DOI: https://doi.org/10.1016/j.ejca.2006.01.020.

Correa P. The biological model of gastric carcinogenesis. IARC SciPubl. 2004;157:301–11.

Ливзан М.А., Кононов А.В., Мозговой С.И. Течение хронического гастрита, ассоциированного Helicobacter pylori, в постэрадикационном периоде. Экспериментальная и клиническая гастроэнтерология. 2007;5:116-123.

Tozzoli R. The diagnostic role of autoantibodies in the prediction of organ-specific autoimmune diseases. ClinChem Lab Med. 2008;46(5): 577–87.

Livzan M.A., Mozgovoj S.I., Kononov A.V. Gastritis after eradication of Helicobacter pylori — simple traces or serious consequences? Lechashchij vrach. 2011;7:7 (In Rus.)

Livzan M.A., Kononov A.V., Mozgovoj S.I. Post-eradication period of chronic gastritis associated with Helicobacter pylori infection. Consilium Medicum. 2008;10(8):15–20. (In Rus.)

Matysiak-Budnik T, Megraud F. Helicobacter pylori infection and gastric cancer. Eur J Cancer. 2006;42(6):708–16. DOI: https://doi.org/10.1016/j.ejca.2006.01.020.

Correa P. The biological model of gastric carcinogenesis. IARC SciPubl. 2004;157:301–11.

Livzan M.A., Kononov A.V., Mozgovoj S.I. The course of chronic gastritis associated with Helicobacter pylori in the post-eradication period. Experimental and clinical gastroenterology. 2007;5:116–123. (In Rus.)

The authors declare that there are no conflicts of interest present.